Medical Oncology, Immunotherapy & Targeted Therapy
Dr. Chandragouda Dodagoudar is a highly acclaimed Medical Oncologist with over 25 years of clinical experience. Known for his “patient-first” philosophy, he is a pioneer in the use of immunotherapy and targeted therapies to treat a vast array of solid tumors and blood cancers. His expertise in precision oncology ensures that each patient receives a treatment plan tailored to their unique genetic and molecular profile.
Dr. Chandragouda is a distinguished name in the oncology circuit, recognized for his academic excellence and his ability to manage complex, multi-stage cancer cases with compassion and clinical precision.
Elite Training: After completing his post-graduation, he earned his DNB in Medical Oncology from the prestigious Rajiv Gandhi Cancer Institute, followed by an ECMO (European Certified Medical Oncologist) certification from Geneva, Switzerland.
Master of Modern Therapy: He is an expert in the “New Age” of cancer treatment—Immunotherapy and Targeted Therapy. These treatments focus on using the body’s own immune system or specific molecular markers to attack cancer cells, often resulting in fewer side effects than traditional chemotherapy.
Global Academic Contributor: With over 40 national and international publications, he is a thought leader in his field. He has served as a Principal Investigator for numerous Phase II and Phase III global clinical trials, bringing the latest life-saving drugs to his patients.
International Trust: Dr. Chandragouda is highly sought after by patients from Kenya, Ethiopia, Nigeria, and Uzbekistan, particularly for his expertise in Breast and Lung cancer management.
Dr. Chandragouda specializes in the medical management of various malignancies using evidence-based protocols.
Solid Tumors: Breast, Lung, Head & Neck, and Gastrointestinal (GI) cancers.
Gynaecologic Cancers: Ovarian, Cervical, and Uterine malignancies.
Genitourinary Cancers: Prostate, Bladder, and Kidney cancers.
Blood Cancers: Lymphoma, Multiple Myeloma, and various types of Leukemia.
Rare Cancers: Sarcomas, Bone cancers, and cancers of unknown primary (MUO).
Chemotherapy: High-precision administration of systemic anti-cancer drugs.
Immunotherapy: Utilizing checkpoint inhibitors and other biological agents to boost the immune response.
Targeted Therapy: Using drugs that specifically target the proteins or genes that help cancer grow.
Hormonal Therapy: Effective management for breast and prostate cancers.
Supportive & Palliative Care: Ensuring the highest quality of life and pain management throughout the treatment journey.
Senior Director & Unit Head: Medical Oncology, BLK-Max Super Speciality Hospital, New Delhi (Present).
Director & Head: Medical Oncology, Aakash Healthcare, Dwarka, New Delhi.
Senior Consultant: Medical Oncology, BLK Super Speciality Hospital, New Delhi.
Consultant: Rajiv Gandhi Cancer Institute & Research Centre, New Delhi.
Senior Resident: Max Healthcare, New Delhi and Apollo Hospitals, Bangalore.
MBBS: University of Mysore (2000).
MD (General Medicine): Rajiv Gandhi University of Health Sciences (2006).
DNB (Medical Oncology): National Board of Examinations (2013).
ECMO: European Certified Medical Oncologist, ESMO, Geneva (2012).
Share your medical concern with us and receive expert guidance from India’s leading specialists. Our international patient care team will review your case, suggest the best treatment options, estimated costs, and assist you with hospital coordination, visa guidance, and travel support – completely free of charge.
Fill out this form and our health expert will get back to you within 24 hours.
